The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

History and Discovery | Structure–Activity Relations and Pharmacological Profile | Pharmacokinetics and Disposition | Mechanism of Action | Indications and Efficacy | Dosing Recommendations | Side Effects and Toxicity | Drug–Drug Interactions | Conclusion | References

Excerpt

During the clinical development of lamotrigine as a treatment for intractable seizures, improved mood in lamotrigine-treated patients was anecdotally reported (Jawad et al. 1989; Smith et al. 1993). In 1993, the addition of lamotrigine to an existing antiepileptic drug regimen was evaluated in a small study of 81 patients with epilepsy (Smith et al. 1993). Lamotrigine-treated patients reported significantly higher levels of happiness and an improvement in perceived internal locus of control. There was no correlation between perceived happiness and changes in seizure frequency or severity. Thus, the investigators preliminarily concluded that lamotrigine may have an effect on mood independent of its antiepileptic effect.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).